Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119-Reference-Cited by-同舟云学术

Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119

Published:2018-09 Issue:9 Volume:1863 Page:1132-1141
ISSN:1388-1981
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Author:

Arifin Syamsul A.,Paternoster Silvano,Carlessi Rodrigo,Casari Ilaria,Ekberg Jeppe Hvidtfeldt,Maffucci Tania,Newsholme Philip,Rosenkilde Mette M.,Falasca Marco

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference45 articles.

1. Incretin-based therapies: where will we be 50 years from now?;Meier;Diabetologia,2015

2. Oral l-glutamine increases active GLP-1 (7–36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats;Badole;Chem. Biol. Interact.,2013

3. Oral l-arginine stimulates GLP-1 secretion to improve glucose tolerance in male mice;Clemmensen;Endocrinology,2013

4. 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans;Hansen;J. Clin. Endocrinol. Metab.,2011

5. GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity;Overton;Br. J. Pharmacol.,2008

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical pharmacokinetics, pharmacodynamics, and toxicity of novel small-molecule GPR119 agonists to treat type-2 diabetes and obesity;Biomedicine & Pharmacotherapy;2024-08

2. G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?;Biomedicine & Pharmacotherapy;2024-03

3. Genetic and biochemical analysis of severe hypertriglyceridemia complicated with acute pancreatitis or with low post-heparin lipoprotein lipase mass;Endocrine Journal;2024

4. Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release;Diabetes;2023-10-20

5. MBOAT7-driven lysophosphatidylinositol acylation in adipocytes contributes to systemic glucose homeostasis;Journal of Lipid Research;2023-04